PLUS THERAPEUTICS, INC. — Director's Dealing 2011

Aug 24, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2011-08-19

Reporting Person: HOLMES E CARMACK (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-08-19	Common Stock	P	3000	$3.15	Acquired	27401	Indirect

Footnotes

F1: These shares are held of record by E. Carmack Holmes %Carolyn K. Holmes TTEE, Holmes Living Trust DD 05/15/92.